Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: Apr 15, 2024

Total Value ($000): $449,227 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 50.2%

Value ($000) $225,584 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 17.6%

Value ($000) $79,274 Shares 7,464,572 Est. Cost $13.72 Unrealized -38.1%

NAMS NEWAMSTERDAM PHARMA COMPANY 15.1%

Value ($000) $67,865 Shares 2,869,565 Est. Cost $10.96 Unrealized +85.3%

— MERUS N V 11.7%

Value ($000) $52,641 Shares 1,169,028 Est. Cost $14.08 Unrealized —

AURA AURA BIOSCIENCES INC 5.3%

Value ($000) $23,863 Shares 3,039,892 Est. Cost $17.87 Unrealized -53.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$225,584	50.2%	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$79,274	17.6%	$13.72	-38.1%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$67,865	15.1%	$10.96	+85.3%	ORDINARY SHARES	N62509109
—	MERUS N V	1,169,028	$52,641	11.7%	$14.08	—	COM	N5749R100
AURA	AURA BIOSCIENCES INC	3,039,892	$23,863	5.3%	$17.87	-53.6%	COM	05153U107